Acumen Pharmaceuticals (ABOS) Change in Acquisitions & Divestments (2022 - 2026)

Acumen Pharmaceuticals' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 57.67% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $135.3 million (down 45.12% YoY), while the FY2025 annual figure was $172.1 million, down 21.34% from the prior year.
• Change in Acquisitions & Divestments came in at $27.0 million for Q1 2026 at Acumen Pharmaceuticals, up from $26.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $88.4 million in Q3 2024 to a low of $4.0 million in Q1 2022.
• A 5-year average of $34.0 million and a median of $34.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 347.44% in 2024 and slumped 57.67% in 2026, its largest moves.
• Acumen Pharmaceuticals' Change in Acquisitions & Divestments stood at $9.0 million in 2022, then jumped by 155.38% to $23.0 million in 2023, then surged by 94.76% to $44.8 million in 2024, then slumped by 41.36% to $26.2 million in 2025, then grew by 2.92% to $27.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $27.0 million, $26.2 million, and $40.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison